[Skip to Content]
[Skip to Content Landing]
Views 2,584
Citations 0
Research Letter
October 28, 2019

Epidemiology of Dementia and Alzheimer Disease in Individuals With Down Syndrome

Author Affiliations
  • 1Waisman Center, University of Wisconsin–Madison, Madison
  • 2Department of Family Medicine and Community Health, University of Wisconsin–Madison, Madison
  • 3School of Human Ecology, University of Wisconsin–Madison, Madison
  • 4School of Social Work, University of Wisconsin–Madison, Madison
JAMA Neurol. 2020;77(2):262-264. doi:10.1001/jamaneurol.2019.3666

The life span has profoundly increased for individuals with Down syndrome (DS), leading to a large, understudied population of middle-aged and older adults with DS.1 Clinical studies show individuals with DS are at higher risk and have earlier onset of dementia.2 Down syndrome is defined by trisomy of chromosome 21, the site of the amyloid precursor protein gene. Overexpression of amyloid precursor protein–produced β-amyloid is hypothesized to increase risk for Alzheimer disease (AD) dementia in individuals with DS.3 Autopsy and neuroimaging studies indicate that by age 40 years, virtually all adults with DS exhibit AD neuropathology.2 However, individuals can live decades with AD neuropathology prior to developing clinical symptoms.4 Research examining prevalence of dementia in individuals with DS has been largely confined to clinic-based convenience samples.3 Population-based epidemiological work is needed to clarify the extent of dementia in DS and illustrate the public health outcomes for the DS population, their families, and health service systems. We describe prevalence and incidence of dementia and AD in DS in a full Medicaid population of adults with DS in Wisconsin from 2008 through 2018.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words